{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:21:46Z","timestamp":1792873306006,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FAECC","award":["FAECC2015\/006"],"award-info":[{"award-number":["FAECC2015\/006"]}]},{"DOI":"10.13039\/501100014139","name":"CIBERONC","doi-asserted-by":"crossref","award":["CB16\/12\/00484"],"award-info":[{"award-number":["CB16\/12\/00484"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01558"],"award-info":[{"award-number":["PI17\/01558"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5693-2","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:03:51Z","timestamp":1558519431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma"],"prefix":"10.1186","volume":"19","author":[{"given":"Rebeca","family":"Burgos-Panadero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Noguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4546-7459","authenticated-orcid":false,"given":"Rosa","family":"Noguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"5693_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.20517\/2394-4722.2016.08","volume":"2","author":"G Xiong","year":"2016","unstructured":"Xiong G, Xu R. Function of cancer cell-derived extracellular matrix in tumor progression. J Cancer Metastasis Treat. 2016;2:357\u201364.","journal-title":"J Cancer Metastasis Treat"},{"issue":"12","key":"5693_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243\u201353.","journal-title":"EMBO Rep"},{"issue":"4","key":"5693_CR3","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.22193","volume":"47","author":"RG Wells","year":"2008","unstructured":"Wells RG. The role of matrix stiffness in regulating cell behavior. Hepatology. 2008;47(4):1394\u2013400.","journal-title":"Hepatology."},{"issue":"7","key":"5693_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc3080","volume":"11","author":"D Wirtz","year":"2011","unstructured":"Wirtz D, Konstantopoulos K, Searson PC. The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer. 2011;11(7):512\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"5693_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1582-4934.2010.01236.x","volume":"15","author":"RV Iozzo","year":"2011","unstructured":"Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med. 2011;15(5):1013\u201331.","journal-title":"J Cell Mol Med"},{"issue":"Suppl 2","key":"5693_CR6","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.breast.2013.07.012","volume":"22","author":"T Oskarsson","year":"2013","unstructured":"Oskarsson T. Extracellular matrix components in breast cancer progression and metastasis. Breast. 2013;22(Suppl 2):S66\u201372.","journal-title":"Breast."},{"issue":"6","key":"5693_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/10428190500051448","volume":"46","author":"T Vincent","year":"2005","unstructured":"Vincent T, Mechti N. Extracellular matrix in bone marrow can mediate drug resistance in myeloma. Leuk Lymphoma. 2005;46(6):803\u201311.","journal-title":"Leuk Lymphoma"},{"issue":"25","key":"5693_CR8","doi-asserted-by":"crossref","first-page":"20946","DOI":"10.18632\/oncotarget.4173","volume":"6","author":"HH Lin","year":"2015","unstructured":"Lin HH, Lin HK, Lin IH, Chiou YW, Chen HW, Liu CY, et al. Mechanical phenotype of cancer cells: cell softening and loss of stiffness sensing. Oncotarget. 2015;6(25):20946\u201358.","journal-title":"Oncotarget."},{"key":"5693_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.cb.07.110191.001423","volume":"7","author":"KT Preissner","year":"1991","unstructured":"Preissner KT. Structure and biological role of vitronectin. Annu Rev Cell Biol. 1991;7:275\u2013310.","journal-title":"Annu Rev Cell Biol"},{"issue":"5","key":"5693_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1357-2725(99)00005-9","volume":"31","author":"I Schvartz","year":"1999","unstructured":"Schvartz I, Seger D, Shaltiel S. Vitronectin. Int J Biochem Cell Biol. 1999;31(5):539\u201344.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"5693_CR11","first-page":"787","volume":"12","author":"D Seiffert","year":"1997","unstructured":"Seiffert D. Constitutive and regulated expression of vitronectin. Histol Histopathol. 1997;12(3):787\u201397.","journal-title":"Histol Histopathol"},{"issue":"5","key":"5693_CR12","first-page":"1631","volume":"150","author":"CL Gladson","year":"1997","unstructured":"Gladson CL, Dennis C, Rotolo TC, Kelly DR, Grammer JR. Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells. Am J Pathol. 1997;150(5):1631\u201346.","journal-title":"Am J Pathol"},{"key":"5693_CR13","first-page":"1457","volume":"12","author":"T Dimova","year":"2005","unstructured":"Dimova T, Georgieva R, Petlov D, Lazarova S. Comparative study on the expression of fibronectin, vitronectin, \u03b15\u03b21, \u03b23 and \u03b1\u03bd integrins in goat and pig adrenal glands. Comptes rendus de l'Academie bulgare des Sciences. 2005;12:1457\u201362.","journal-title":"Comptes rendus de l'Academie bulgare des Sciences"},{"issue":"11","key":"5693_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/sj.bjc.6603467","volume":"95","author":"S Edwards","year":"2006","unstructured":"Edwards S, Lalor PF, Tuncer C, Adams DH. Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta3-independent manner. Br J Cancer. 2006;95(11):1545\u201354.","journal-title":"Br J Cancer"},{"issue":"5","key":"5693_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF02633989","volume":"29A","author":"H Yasumitsu","year":"1993","unstructured":"Yasumitsu H, Seo N, Misugi E, Morita H, Miyazaki K, Umeda M. Vitronectin secretion by hepatic and non-hepatic human cancer cells. In Vitro Cell Dev Biol Anim. 1993;29A(5):403\u20137.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"5","key":"5693_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/BF00349063","volume":"59","author":"KT Preissner","year":"1989","unstructured":"Preissner KT. The role of vitronectin as multifunctional regulator in the hemostatic and immune systems. Blut. 1989;59(5):419\u201331.","journal-title":"Blut."},{"issue":"5","key":"5693_CR17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1083\/jcb.200612058","volume":"177","author":"CD Madsen","year":"2007","unstructured":"Madsen CD, Ferraris GM, Andolfo A, Cunningham O, Sidenius N. uPAR-induced cell adhesion and migration: vitronectin provides the key. J Cell Biol. 2007;177(5):927\u201339.","journal-title":"J Cell Biol"},{"issue":"6","key":"5693_CR18","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1172\/JCI115516","volume":"88","author":"CL Gladson","year":"1991","unstructured":"Gladson CL, Cheresh DA. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest. 1991;88(6):1924\u201332.","journal-title":"J Clin Invest"},{"issue":"43","key":"5693_CR19","doi-asserted-by":"publisher","first-page":"69829","DOI":"10.18632\/oncotarget.12003","volume":"7","author":"G Schneider","year":"2016","unstructured":"Schneider G, Bryndza E, Poniewierska-Baran A, Serwin K, Suszynska M, Sellers ZP, et al. Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavities. Oncotarget. 2016;7(43):69829\u201343.","journal-title":"Oncotarget."},{"issue":"9","key":"5693_CR20","first-page":"11364","volume":"8","author":"K Shi","year":"2015","unstructured":"Shi K, Lan RL, Tao X, Wu CY, Hong HF, Lin JH. Vitronectin significantly influences prognosis in osteosarcoma. Int J Clin Exp Pathol. 2015;8(9):11364\u201371.","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"5693_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc3526","volume":"13","author":"NK Cheung","year":"2013","unstructured":"Cheung NK, Dyer MA. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer. 2013;13(6):397\u2013411.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"5693_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","volume":"27","author":"SL Cohn","year":"2009","unstructured":"Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol. 2009;27(2):289\u201397.","journal-title":"J Clin Oncol"},{"issue":"4","key":"5693_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/bjc.2016.210","volume":"115","author":"I Tadeo","year":"2016","unstructured":"Tadeo I, Berbegall A, Castel V, Garc\u00eda-Miguel P, Callaghan R, P\u00e5hlman S, et al. Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort. Br J Cancer. 2016;115(4):480\u20139.","journal-title":"Br J Cancer"},{"key":"5693_CR24","doi-asserted-by":"publisher","unstructured":"Tadeo I, Berbegall A, Navarro S, Castel V, Noguera R. A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors. Pediatr Blood Cancer. 2017;64(9). https:\/\/doi.org\/10.1002\/pbc.26449 .","DOI":"10.1002\/pbc.26449"},{"issue":"15","key":"5693_CR25","doi-asserted-by":"publisher","first-page":"19935","DOI":"10.18632\/oncotarget.7661","volume":"7","author":"I Tadeo","year":"2016","unstructured":"Tadeo I, Bueno G, Berbegall A, Fern\u00e1ndez-Carrobles M, Castel V, Garc\u00eda-Rojo M, et al. Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors. Oncotarget. 2016;7(15):19935\u201347.","journal-title":"Oncotarget."},{"key":"5693_CR26","first-page":"487","volume":"33","author":"I Tadeo","year":"2018","unstructured":"Tadeo I, Gamero-Sandemetrio E, Berbegall AP, Navarro S, Ca\u00f1ete A, Noguera R. 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors. Histol Histopathol. 2018;33:487\u201395.","journal-title":"Histol Histopathol"},{"issue":"3","key":"5693_CR27","first-page":"712","volume":"60","author":"A Erdreich-Epstein","year":"2000","unstructured":"Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, et al. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res. 2000;60(3):712\u201321.","journal-title":"Cancer Res"},{"key":"5693_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fonc.2014.00202","volume":"4","author":"IM Ambros","year":"2014","unstructured":"Ambros IM, Brunner C, Abbasi R, Frech C, Ambros PF. Ultra-high density SNParray in neuroblastoma molecular diagnostics. Front Oncol. 2014;4:202.","journal-title":"Front Oncol"},{"issue":"8","key":"5693_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1158\/1541-7786.MCR-15-0366","volume":"14","author":"AM Lavorato-Rocha","year":"2016","unstructured":"Lavorato-Rocha AM, Akagi EM, de Melo Maia B, Rodrigues IS, Botelho MC, Marchi FA, et al. An integrative approach uncovers biomarkers that associate with clinically relevant disease outcomes in vulvar carcinoma. Mol Cancer Res. 2016;14(8):720\u20139.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"5693_CR30","first-page":"2527","volume":"13","author":"Y Niu","year":"2016","unstructured":"Niu Y, Zhang L, Bi X, Yuan S, Chen P. Evaluation of Vitronectin expression in prostate Cancer and the clinical significance of the Association of Vitronectin Expression with prostate specific antigen in detecting prostate Cancer. Urol J. 2016;13(1):2527\u201332.","journal-title":"Urol J"},{"issue":"7","key":"5693_CR31","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ijc.30202","volume":"139","author":"I Ortega-Martinez","year":"2016","unstructured":"Ortega-Martinez I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, Cortes J, Garcia-Vazquez MD, et al. Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma. Int J Cancer. 2016;139(7):1598\u2013607.","journal-title":"Int J Cancer"},{"issue":"10","key":"5693_CR32","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jpedsurg.2004.06.011","volume":"39","author":"P Li","year":"2004","unstructured":"Li P, Gao Y, Ji Z, Zhang X, Xu Q, Li G, et al. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma. J Pediatr Surg. 2004;39(10):1512\u20139.","journal-title":"J Pediatr Surg"},{"issue":"3","key":"5693_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.semnephrol.2015.04.006","volume":"35","author":"CC Nast","year":"2015","unstructured":"Nast CC, Lemley KV, Hodgin JB, Bagnasco S, Avila-Casado C, Hewitt SM, et al. Morphology in the digital age: integrating high-resolution description of structural alterations with phenotypes and genotypes. Semin Nephrol. 2015;35(3):266\u201378.","journal-title":"Semin Nephrol"},{"issue":"6","key":"5693_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1586\/14737159.8.6.707","volume":"8","author":"L Mulrane","year":"2008","unstructured":"Mulrane L, Rexhepaj E, Penney S, Callanan JJ, Gallagher WM. Automated image analysis in histopathology: a valuable tool in medical diagnostics. Expert Rev Mol Diagn. 2008;8(6):707\u201325.","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"5693_CR35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1172\/JCI33775","volume":"118","author":"HA Kenny","year":"2008","unstructured":"Kenny HA, Kaur S, Coussens LM, Lengyel E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest. 2008;118(4):1367\u201379.","journal-title":"J Clin Invest"},{"key":"5693_CR36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1242\/jcs.108.3.947","volume":"108","author":"CL Gladson","year":"1995","unstructured":"Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci. 1995;108 ( Pt 3:947\u201356.","journal-title":"J Cell Sci"},{"issue":"12","key":"5693_CR37","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2012-08-451187","volume":"121","author":"V Pirazzoli","year":"2013","unstructured":"Pirazzoli V, Ferraris GM, Sidenius N. Direct evidence of the importance of vitronectin and its interaction with the urokinase receptor in tumor growth. Blood. 2013;121(12):2316\u201323.","journal-title":"Blood."},{"issue":"25","key":"5693_CR38","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1038\/onc.2013.274","volume":"33","author":"C Chang","year":"2014","unstructured":"Chang C, Lee SO, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 2014;33(25):3225\u201334.","journal-title":"Oncogene."},{"key":"5693_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ceb.2016.03.006","volume":"40","author":"DM nGraham","year":"2016","unstructured":"nGraham DM, Burridge K. Mechanotransduction and nuclear function. Curr Opin Cell Biol. 2016;40:98\u2013105.","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"5693_CR40","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/bcr1398","volume":"8","author":"EK Sloan","year":"2006","unstructured":"Sloan EK, Pouliot N, Stanley KL, Chia J, Moseley JM, Hards DK, et al. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res. 2006;8(2):R20.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"5693_CR41","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1038\/s41598-017-10062-1","volume":"7","author":"CD Mauro","year":"2017","unstructured":"Mauro CD, Pesapane A, Formisano L, Rosa R, D'Amato V, Ciciola P, et al. Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors. Sci Rep. 2017;7(1):9388.","journal-title":"Sci Rep"},{"issue":"3","key":"5693_CR42","first-page":"238","volume":"24","author":"N Harbeck","year":"2001","unstructured":"Harbeck N, Kruger A, Sinz S, Kates RE, Thomssen C, Schmitt M, et al. Clinical relevance of the plasminogen activator inhibitor type 1--a multifaceted proteolytic factor. Onkologie. 2001;24(3):238\u201344.","journal-title":"Onkologie."},{"issue":"2","key":"5693_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000360085","volume":"51","author":"R Li","year":"2014","unstructured":"Li R, Luo M, Ren M, Chen N, Xia J, Deng X, et al. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis. J Vasc Res. 2014;51(2):110\u20137.","journal-title":"J Vasc Res"},{"key":"5693_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.addr.2015.10.007","volume":"97","author":"AW Holle","year":"2016","unstructured":"Holle AW, Young JL, Spatz JP. In vitro cancer cell-ECM interactions inform in vivo cancer treatment. Adv Drug Deliv Rev. 2016;97:270\u20139.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"5693_CR45","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s10637-010-9616-y","volume":"29","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Yang M, Ji Q, Fan D, Peng H, Yang C, et al. Anoikis induction and metastasis suppression by a new integrin alphavbeta3 inhibitor in human melanoma cell line M21. Investig New Drugs [Internet. 2011;29(4):666\u201373.","journal-title":"Investig New Drugs"},{"key":"5693_CR46","first-page":"15","volume":"15","author":"N Montuori","year":"2016","unstructured":"Montuori N, Pesapane A, Rossi FW, Giudice V, De Paulis A, Selleri C, et al. Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer. Transl Med UniSa. 2016;15:15\u201321.","journal-title":"Transl Med UniSa"},{"issue":"7","key":"5693_CR47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.7150\/thno.4218","volume":"3","author":"H Noh","year":"2013","unstructured":"Noh H, Hong S, Huang S. Role of urokinase receptor in tumor progression and development. Theranostics. 2013;3(7):487\u201395.","journal-title":"Theranostics."},{"issue":"1","key":"5693_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrm2821","volume":"11","author":"HW Smith","year":"2010","unstructured":"Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol. 2010;11(1):23\u201336.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5693_CR49","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1593\/neo.10296","volume":"10","author":"SA Rabbani","year":"2010","unstructured":"Rabbani SA, Ateeq B, Arakelian A, Valentino ML, Shaw DE, Dauffenbach LM, et al. An anti-Urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate Cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo. Neoplasia. 2010;10:778\u201388.","journal-title":"Neoplasia."},{"issue":"1","key":"5693_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s000180050497","volume":"57","author":"PA Andreasen","year":"2000","unstructured":"Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci. 2000;57(1):25\u201340.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"5693_CR51","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccr.2008.08.012","volume":"14","author":"K Bajou","year":"2008","unstructured":"Bajou K, Peng H, Laug WE, Maillard C, Noel A, Foidart JM, et al. Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell. 2008;14(4):324\u201334.","journal-title":"Cancer Cell"},{"issue":"11","key":"5693_CR52","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/1535-7163.MCT-13-0041","volume":"12","author":"T Masuda","year":"2013","unstructured":"Masuda T, Hattori N, Senoo T, Akita S, Ishikawa N, Fujitaka K, et al. SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis. Mol Cancer Ther. 2013;12(11):2378\u201388.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"5693_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133786","volume":"10","author":"VR Placencio","year":"2015","unstructured":"Placencio VR, Ichimura A, Miyata T, DeClerck YA. Small molecule inhibitors of plasminogen activator Inhibitor-1 elicit anti-tumorigenic and anti-Angiogenic activity. PLoS One. 2015;10(7):e0133786.","journal-title":"PLoS One"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5693-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T08:03:28Z","timestamp":1663488208000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5693-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5693"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5693-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"19 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee of the University of Valencia (reference B.0000339 29\/01\/2015). Participants or their family members\/legal guardians provided written informed consent for histological and genetic studies performed in our laboratory.The animal experiments were carried out in accordance with the standards and care approved by the institutional ethical animal care committee (reference 2015\/VSC\/PEA\/00083).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"479"}}